Back to Authors

GROUP, REDUCE STUDY

Mayo Clinic

No affiliation available

Citations 1

CHEMOPREVENTION OF PROSTATE CANCER IN MEN AT HIGH RISK: RATIONALE AND DESIGN OF THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL

Journal of Urology | September 15, 2004 | Volume: 172 | Issue: 4 Part 1 | Pages: 1314-1317

10.1097/01.ju.0000139320.78673.2a | PMID 15371831